Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin and L-carnitine for Cardioprotection in Anthracycline Chemotherapy
NCT04434404Phase 4Completed
- Sponsor
- Horus Pharma
- Start
- Sep 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levocarnitine, silymarin in Cardiotoxicity, sponsored by Horus Pharma. Started Sep 2018; status: completed.
02
Drugs
levocarnitinesilymarin
03
Conditions
Cardiotoxicity
Beyond the preview
Go deeper on NCT04434404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04434404.